应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
90050 鹰瞳科技
提前休市 12-24 12:00:00
0.000
+0.000
--
最高
0.000
最低
0.000
成交量
0.00
今开
0.000
昨收
0.000
日振幅
0.00%
总市值
0.00
流通市值
0.00
总股本
0.00
成交额
0.00
换手率
--
流通股本
0.00
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）
资讯
新帖
简况
把它当悬疑剧看，你就错了
虎嗅 · 2023-01-28
把它当悬疑剧看，你就错了
鹰瞳科技-B(02251.HK)温和走强，午后升约7%
证券之星 · 2023-01-27
鹰瞳科技-B(02251.HK)温和走强，午后升约7%
港股异动 | 鹰瞳科技-B(02251)涨7% 向IndexCap Med&Tech I L.P.注资1,450万美元
智通财经网 · 2023-01-27
港股异动 | 鹰瞳科技-B(02251)涨7% 向IndexCap Med&Tech I L.P.注资1,450万美元
鹰瞳科技－Ｂ(02251.HK)向合伙注资1,450万美元 物色海外投资目标
阿斯达克财经 · 2023-01-26
鹰瞳科技－Ｂ(02251.HK)向合伙注资1,450万美元 物色海外投资目标
鹰瞳科技-B(02251)认购IndexCap Med&Tech的有限合伙权益
智通财经 · 2023-01-25
鹰瞳科技-B(02251)认购IndexCap Med&Tech的有限合伙权益
鹰瞳科技-B(02251.HK)公布，于本公告日期，高斐已呈辞执行董事以便投入更多时间至其家庭及其他工作安排，即时生效
证券之星 · 2023-01-13
鹰瞳科技-B(02251.HK)公布，于本公告日期，高斐已呈辞执行董事以便投入更多时间至其家庭及其他工作安排，即时生效
鹰瞳科技-B(02251)提名朱艇遥为非执行董事的候选人
智通财经 · 2023-01-13
鹰瞳科技-B(02251)提名朱艇遥为非执行董事的候选人
鹰瞳科技-B(02251)：建议采纳2022年股权激励计划
智通财经 · 2023-01-13
鹰瞳科技-B(02251)：建议采纳2022年股权激励计划
鹰瞳科技-B(02251.HK)盘中涨近11%，截至发稿，涨8.52%，报13.24港元
证券之星 · 2023-01-13
鹰瞳科技-B(02251.HK)盘中涨近11%，截至发稿，涨8.52%，报13.24港元
智通港股投资日志|11月10日
智通财经 · 2022-11-10
智通港股投资日志|11月10日
加载更多
公司概况
公司名称：
鹰瞳科技
所属市场：
SEHK
上市日期：
--
主营业务：
鹰瞳Airdoc是全球视网膜影像人工智能领域的领导者和先行者，公司基于视网膜影像人工智能识别的早期检测、辅助诊断及健康风险评估解决方案，通过视网膜影像、多模态数据分析以及人工智能深度学习算法，改善了慢性病传统的早期检测及诊断方式，在医疗机构和大健康场景中实现对慢性病的无创、精确、快速、高性价比且大规模的诊断及相关健康风险评估。
发行价格：
--
{"stockData":{"symbol":"90050","market":"HK","secType":"STK","nameCN":"鹰瞳科技","latestPrice":0,"timestamp":1735012800000,"preClose":0,"halted":9,"volume":0,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"提前休市","marketStatusCode":6,"change":0,"latestTime":"12-24 12:00:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1735263000000},"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1735003800000,1735012800000]],"volumeRatio":0,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/90050","defaultTab":"news","newsList":[{"id":"2306255913","title":"把它当悬疑剧看，你就错了","url":"https://stock-news.laohu8.com/highlight/detail?id=2306255913","media":"虎嗅","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2306255913?lang=zh_cn&edition=full","pubTime":"2023-01-28 22:35","pubTimestamp":1674916530,"startTime":"0","endTime":"0","summary":"《平原》的故事是一个玫瑰色的怀旧乌托邦。","market":"sh","thumbnail":"https://img.huxiucdn.com/article/cover/202301/28/220725890608.jpg?imageView2/1/w/720/h/405/|imageMogr2/strip/interlace/1/quality/85/format/jpg","type":0,"news_type":0,"thumbnails":["https://img.huxiucdn.com/article/cover/202301/28/220725890608.jpg?imageView2/1/w/720/h/405/|imageMogr2/strip/interlace/1/quality/85/format/jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.huxiu.com/article/779141.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_huxiu","symbols":["BK1189","90050","02251"],"gpt_icon":0},{"id":"2306857425","title":"鹰瞳科技-B(02251.HK)温和走强，午后升约7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2306857425","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2306857425?lang=zh_cn&edition=full","pubTime":"2023-01-27 14:50","pubTimestamp":1674802226,"startTime":"0","endTime":"0","summary":"截至发稿，鹰瞳科技涨7.23%，报14.24港元，市值14.75亿港元。截至2023年1月26日收盘，鹰瞳科技-B报收于13.28港元，上涨1.84%，换手率0.12%，成交量12.45万股，成交额166.38万港元。投行对该股关注度不高，90天内无投行对其给出评级。鹰瞳科技-B港股市值3.44亿港元，在医疗服务Ⅱ行业中排名第41。主要指标见下表：以上内容由证券之星根据公开信息整理，与本站立场无关。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023012700000700.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["90050","02251","BK1189"],"gpt_icon":0},{"id":"2306423409","title":"港股异动 | 鹰瞳科技-B(02251)涨7% 向IndexCap Med&Tech I L.P.注资1,450万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2306423409","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2306423409?lang=zh_cn&edition=full","pubTime":"2023-01-27 14:34","pubTimestamp":1674801255,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，鹰瞳科技-B温和走强，午后升约7%。截至发稿，鹰瞳科技涨7.23%，报14.24港元，市值14.75亿港元。日前，鹰瞳科技宣布，向合伙IndexCap Med&Tech I L.P.注资合共1,450万美元。稍早，公司主席兼CEO张大磊表示，希望鹰瞳Airdoc视网膜影像人工智能检测产品能服务超2000万人群。鹰瞳科技主要专注于提供人工智能视网膜影像识别的早期检测、诊断及健康风险评估解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/866858.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1189","02251","90050"],"gpt_icon":0},{"id":"2306430768","title":"鹰瞳科技－Ｂ(02251.HK)向合伙注资1,450万美元 物色海外投资目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2306430768","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2306430768?lang=zh_cn&edition=full","pubTime":"2023-01-26 09:59","pubTimestamp":1674698340,"startTime":"0","endTime":"0","summary":"鹰瞳科技－Ｂ(02251.HK) 公布，其全资附属香港爱道订立认购协议，向合伙IndexCap Med&Tech I L.P.注资合共1,450万美元。IndexCap Med&Tech I L.P.专注于投资普通合伙人认为合适的海外医疗健康及科技行业公司。公司指出，通过投资于合伙，公司将能够利用IndexCap Med&Tech及Index Capital的专业知识及资源物色海外市场上的投资目标，为其现有业务创造协同反应并发展集团的海外业务；并为公司提供机会补全其于医疗器械、医疗及与其业务相关其他行业的战略布局，提升其竞争力及巩固其市场地位。(jl/u)(港股报价延迟最少十五分钟。)","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20220216122106578_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20220216122106578_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1240879/latest-news/HK6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02251","BK1189","90050"],"gpt_icon":0},{"id":"2306108082","title":"鹰瞳科技-B(02251)认购IndexCap Med&Tech的有限合伙权益","url":"https://stock-news.laohu8.com/highlight/detail?id=2306108082","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2306108082?lang=zh_cn&edition=full","pubTime":"2023-01-25 19:32","pubTimestamp":1674646336,"startTime":"0","endTime":"0","summary":"智通财经APP讯，鹰瞳科技-B 发布公告，于2023年1月24日，香港爱道与合伙及 IndexCap Med&Tech订立认购协议，香港爱道同意认购合伙的有限合伙权益，资本承担为1450万美元;及根据有限合伙协议的条款及条件成为合伙的有限合伙人。同日，IndexCap Med&Tech及初始有限合伙人订立有限合伙协议，以规管合伙人之间的关系，并规范合伙的管理。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/866280.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1189","90050","02251"],"gpt_icon":0},{"id":"2303885583","title":"鹰瞳科技-B(02251.HK)公布，于本公告日期，高斐已呈辞执行董事以便投入更多时间至其家庭及其他工作安排，即时生效","url":"https://stock-news.laohu8.com/highlight/detail?id=2303885583","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2303885583?lang=zh_cn&edition=full","pubTime":"2023-01-13 23:01","pubTimestamp":1673622068,"startTime":"0","endTime":"0","summary":"由于他辞任执行董事，其不再担任公司薪酬与考核委员会的成员;及王谧由于其他工作安排已呈辞非执行董事，即时生效。截至2023年1月13日收盘，鹰瞳科技-B报收于13.42港元，上涨10.0%，换手率0.17%，成交量17.9万股，成交额235.96万港元。投行对该股关注度不高，90天内无投行对其给出评级。鹰瞳科技-B港股市值3.16亿港元，在医疗服务Ⅱ行业中排名第40。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023011300029953.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["02251","90050","BK1189"],"gpt_icon":0},{"id":"2303780000","title":"鹰瞳科技-B(02251)提名朱艇遥为非执行董事的候选人","url":"https://stock-news.laohu8.com/highlight/detail?id=2303780000","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2303780000?lang=zh_cn&edition=full","pubTime":"2023-01-13 22:56","pubTimestamp":1673621792,"startTime":"0","endTime":"0","summary":"于2023年1月13日举行的董事会会议期间，董事会议决提名王林为第一届董事会执行董事及委任王林为薪酬与考核委员会成员的候选人，及提名朱艇遥为第一届董事会非执行董事的候选人;由股东批准提呈委任王林及朱艇遥供公司2023年第一次股东特别大会审议及批准。同时，委任王林为执行董事及委任朱艇遥为非执行董事将于股东在股东特别大会上批准后生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/862121.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1189","90050","02251"],"gpt_icon":0},{"id":"2303580013","title":"鹰瞳科技-B(02251)：建议采纳2022年股权激励计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2303580013","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2303580013?lang=zh_cn&edition=full","pubTime":"2023-01-13 22:45","pubTimestamp":1673621117,"startTime":"0","endTime":"0","summary":"智通财经APP讯，鹰瞳科技-B(02251)发布公告，董事会已于2023年1月13日举行的董事会会议上议决提呈采纳2022年股权激励计划。该计划仍有待股东于股东特别大会上审议并批准。根据该计划可授予的激励股份的最大数量不得超过621.4万股H股，占截至本公告日期已发行股份总数的6%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/862117.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["90050","BK1189","02251"],"gpt_icon":0},{"id":"2303250148","title":"鹰瞳科技-B(02251.HK)盘中涨近11%，截至发稿，涨8.52%，报13.24港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2303250148","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2303250148?lang=zh_cn&edition=full","pubTime":"2023-01-13 11:20","pubTimestamp":1673580030,"startTime":"0","endTime":"0","summary":"截至2023年1月12日收盘，鹰瞳科技-B报收于12.2元，下跌0.97%，换手率0.11%，成交量11.73万股，成交额154.0万元。投行对该股关注度不高，90天内无投行对其给出评级。鹰瞳科技-B港股市值3.16亿港元，在医疗服务Ⅱ行业中排名第40。主要指标见下表：以上内容由证券之星根据公开信息整理，与本站立场无关。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023011300003536.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["90050","02251","BK1189"],"gpt_icon":0},{"id":"2282188017","title":"智通港股投资日志|11月10日","url":"https://stock-news.laohu8.com/highlight/detail?id=2282188017","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2282188017?lang=zh_cn&edition=full","pubTime":"2022-11-10 00:00","pubTimestamp":1668009602,"startTime":"0","endTime":"0","summary":"智通财经APP统计，2022年11月10日，港股上市公司投资日志如下： 类别 公司 业绩公布日明梁控股荣晖控股森浩集团阿仕特朗金融洪桥集团裕元集团上海青浦消防陆庆娱乐仁德资源朝威控股 股东大会召开日首沣控股东正金融中电光谷北京燃气蓝天邮储银行阳光房地产基金中国恒有源集团鹰瞳科技-B南顺(香港)百心安-B 分红派息中国宏桥（除净日）","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/827475.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02251","90050","BK1189"],"gpt_icon":0}],"profile":{"websiteUrl":"https://www.airdoc.com/","compareEarnings":[{"period":"1week","weight":0.0044},{"period":"1month","weight":0.034},{"period":"3month","weight":0.0464},{"period":"6month","weight":0.0991},{"period":"1year","weight":0.2168},{"period":"ytd","weight":0.1663}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"鹰瞳Airdoc是全球视网膜影像人工智能领域的领导者和先行者，公司基于视网膜影像人工智能识别的早期检测、辅助诊断及健康风险评估解决方案，通过视网膜影像、多模态数据分析以及人工智能深度学习算法，改善了慢性病传统的早期检测及诊断方式，在医疗机构和大健康场景中实现对慢性病的无创、精确、快速、高性价比且大规模的诊断及相关健康风险评估。","exchange":"SEHK","name":"鹰瞳科技","nameEN":"Beijing Airdoc Technology Co., Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"鹰瞳科技(90050)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供鹰瞳科技(90050)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"鹰瞳科技,90050,鹰瞳科技股票,鹰瞳科技股票老虎,鹰瞳科技股票老虎国际,鹰瞳科技行情,鹰瞳科技股票行情,鹰瞳科技股价,鹰瞳科技股市,鹰瞳科技股票价格,鹰瞳科技股票交易,鹰瞳科技股票购买,鹰瞳科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"鹰瞳科技(90050)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供鹰瞳科技(90050)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}